Publications by authors named "Porter Anderson"

Claim this Profile
A
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines.
Michael Pichichero, Richard Malley, Ravinder Kaur, Robert Zagursky, Porter Anderson

Expert Rev Vaccines· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults.
Cheryl A Keech, Royce Morrison, Porter Anderson, Andrea Tate, Jorge Flores

Pediatr Infect Dis J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leaning in to the power of the possible: the crucial role of women scientists on preventing Haemophilus influenzae type b disease.
Katherine L O'Brien, Porter W Anderson

Pediatr Infect Dis J· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability.
Viviane M Gonçalves, Waldely O Dias, Ivana B Campos, Celia Liberman, Maria E Sbrogio-Almeida, Porter Anderson

Vaccine· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine.
Kristin L Moffitt, Puja Yadav, Daniel M Weinberger, Porter W Anderson, Richard Malley

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.
Ying-Jie Lu, Fan Zhang, Sabina Sayeed, Claudette M Thompson, Shousun Szu, Porter W Anderson

Vaccine· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A lucky career in bacterial vaccines.
Porter W Anderson

Hum Vaccin Immunother· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.
Richard Malley, Porter W Anderson

Proc Natl Acad Sci U S A· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QnAs with Porter W. Anderson, Jr. Interview by Nicholette Zeliadt.
Porter W Anderson

Proc Natl Acad Sci U S A· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.
Ying-Jie Lu, Luciana Leite, Viviane Maimoni Gonçalves, Waldely de Oliveira Dias, Celia Liberman, Porter Anderson

Vaccine· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.
Ying-Jie Lu, Puja Yadav, John D Clements, Sophie Forte, Amit Srivastava, Porter W Anderson

Clin Vaccine Immunol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide.
Ying-Jie Lu, Ian Chr Skovsted, Claudette M Thompson, Porter W Anderson, Richard Malley

Microb Pathog· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal capsular polysaccharide structure predicts serotype prevalence.
Daniel M Weinberger, Krzysztof Trzciński, Ying-Jie Lu, Debby Bogaert, Aaron Brandes, Porter W Anderson

PLoS Pathog· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
Ying-Jie Lu, Sophie Forte, Claudette M Thompson, Porter W Anderson, Richard Malley

Infect Immun· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-17A mediates acquired immunity to pneumococcal colonization.
Ying-Jie Lu, Jane Gross, Debby Bogaert, Adam Finn, Linda Bagrade, Porter W Anderson

PLoS Pathog· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
Richard Malley, Amit Srivastava, Marc Lipsitch, Claudette M Thompson, Claire Watkins, Porter W Anderson

Infect Immun· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.
Richard Malley, Krzysztof Trzcinski, Amit Srivastava, Claudette M Thompson, Porter W Anderson

Proc Natl Acad Sci U S A· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant.
Richard Malley, Sarah C Morse, Luciana C C Leite, Ana Paula Mattos Areas, Paulo Lee Ho, Porter Anderson

Infect Immun· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in 2-year-old children.
Porter Anderson, John Treanor, Susan Porcelli, Michael Pichichero

Vaccine· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis